Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial
Top Cited Papers
- 1 April 2007
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 119 (4) , 1019-1021
- https://doi.org/10.1016/j.jaci.2006.12.608
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- How epidemiology has challenged 3 prevailing concepts about atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal HomeostasisCell, 2004
- Toll-Like Receptor 4 Signaling by Intestinal Microbes Influences Susceptibility to Food AllergyThe Journal of Immunology, 2004
- Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trialThe Lancet, 2003
- Atopiform dermatitis: do we need another confusing name for atopic dermatitis?British Journal of Dermatology, 2002
- Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trialThe Lancet, 2001
- Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developingJournal of Allergy and Clinical Immunology, 2001
- Evaluation of the gut mucosal barrier: Evidence for increased antigen transfer in children with atopic eczema+Journal of Allergy and Clinical Immunology, 1996